Yarahmadi Shahin, Nikkhoo Bahram, Parvizi Hesam, Motaghi Rozhin, Rahmani Khaled
Department of Endocrinology and Metabolism, Ministry of Health and Medical Education, Tehran, Iran.
Department of Pathology, School of Medicine, Kurdistan University of Medical Sciences, Sanandaj, Iran.
Int J Endocrinol Metab. 2022 Dec 25;21(1):e131081. doi: 10.5812/ijem-131081. eCollection 2023 Jan.
The newborn screening program for diagnosing and treating children with congenital hypothyroidism (CH) in Iran was established in 2004.
This study aimed to evaluate the national program's success in maintaining the physical development and anthropometric indexes of children with CH.
This historical cohort study was carried out in five provinces located in five different geographical regions of Iran. The anthropometric indexes, including weight, height, and head circumference of 240 children diagnosed with transient congenital hypothyroidism (TCH) (n = 131) and permanent congenital hypothyroidism (PCH) (n = 109) were measured and compared with those of 240 healthy children aged six.
Mean ± standard deviation (SD) of weight, height, and head circumference of children with CH aged six were 20304.8 ± 4457.9 g, 115.6 ± 5.9 cm, and 50.8 ± 1.7 cm, respectively. Mean ± SD of height (116.7 ± 6.1 cm) and head circumference (51.1 ± 1.7 cm) in the control (healthy) group were significantly higher than those of the CH children group (P < 0.05). Mean ± SD weight in the control group (20741.2 ± 4337.3 g) was higher than that in the CH group (20304.8 ± 4457.9 g). However, the difference was not statistically significant (P = 0.3). No significant difference was observed between TCH and PCH children in the subgroup analysis (P > 0.05).
Although the mean of anthropometric indexes in CH patients was slightly lower than that in healthy children aged six, the difference between the two groups was insignificant. The physical development of children with CH was evaluated as good. Our results suggested that the newborn screening program for identifying and treating children with CH in Iran may have improved the growth outcomes.
伊朗于2004年设立了先天性甲状腺功能减退症(CH)患儿诊断与治疗的新生儿筛查项目。
本研究旨在评估该国家项目在维持CH患儿身体发育和人体测量指标方面的成效。
这项历史性队列研究在伊朗五个不同地理区域的省份开展。测量了240例诊断为暂时性先天性甲状腺功能减退症(TCH)(n = 131)和永久性先天性甲状腺功能减退症(PCH)(n = 109)患儿的人体测量指标,包括体重、身高和头围,并与240例6岁健康儿童的指标进行比较。
6岁CH患儿体重、身高和头围的均值±标准差(SD)分别为20304.8±4457.9 g、115.6±5.9 cm和50.8±1.7 cm。对照组(健康)儿童的身高均值±SD(116.7±6.1 cm)和头围均值±SD(51.1±1.7 cm)显著高于CH患儿组(P < 0.05)。对照组的体重均值±SD(20741.2±4337.3 g)高于CH组(20304.8±4457.9 g)。然而,差异无统计学意义(P = 0.3)。亚组分析中,TCH和PCH患儿之间未观察到显著差异(P > 0.05)。
尽管CH患者的人体测量指标均值略低于6岁健康儿童,但两组之间的差异不显著。CH患儿的身体发育评估为良好。我们的结果表明,伊朗识别和治疗CH患儿的新生儿筛查项目可能改善了生长结局。